Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.99
-0.0400-1.32%
Post-market: 2.990.00000.00%19:59 EDT
Volume:106.72K
Turnover:326.17K
Market Cap:58.32M
PE:-1.55
High:3.15
Open:3.02
Low:2.99
Close:3.03
Loading ...
Feb 03, 2022

Major Issues Report

8-K - Current report
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 21, 2021

Major Issues Report

8-K - Current report
Oct 13, 2021

Major Issues Report

8-K - Current report
Sep 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 10, 2021

Major Issues Report

8-K - Current report
Sep 03, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 24, 2021

Major Issues Report

8-K - Current report
Aug 20, 2021

Major Issues Report

8-K - Current report
Aug 19, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 07, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 06, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 25, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jun 04, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 03, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 28, 2021

Major Issues Report

8-K - Current report
May 28, 2021

Major Issues Report

8-K - Current report